Innovative therapeutics

About us

Joshua A. Grass

Senior Vice President, Business & Corporate Development

Joshua A. Grass

Josh Grass joined BioMarin in 2002 as Head of Investor and Financial Relations and was directly involved in raising approximately $1 billion in capital for BioMarin. Since 2006, Mr. Grass has been Head of Business and Corporate Development, currently as Senior Vice President reporting to the CEO, leading the company’s initiatives on corporate strategy, mergers and acquisitions, and technology licensing.
For two years prior to joining BioMarin, Grass was an Associate at the investment bank Vrolyk & Company, focusing on mergers and acquisitions and private equity financings. Prior to that he was a Research Analyst at BioMedical Insights where he conducted strategic market research for established biopharmaceutical and emerging product development companies. Grass also worked in the biotechnology equity research group at SG Cowen between his first and second year of graduate studies in business.
Grass started his career in biotechnology as a Research Scientist at Cerus Corporation where for five years he focused on research and development in the areas of cell biology and immunology. Grass holds a B.S. in Biology from California Polytechnic State University in San Luis Obispo and an MBA in Finance from the University of Rochester in Rochester, New York.

-Updated April 2016



Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS



Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361

Global Medical Information

Contact Global Medical Information